CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel

GlobeNewswire•July 15, 2020 Significantly higher serum concentration and absorption Showcases CUREform™ encapsulation and oral thin film technology OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD) oral thin film (OTF) showed improved bioavailability of cannabidiol in healthy subjects,…